RHT — Resonance Health Cashflow Statement
0.000.00%
Last trade - 00:00- AU$37.82m
- AU$32.24m
- AU$4.51m
- 70
- 35
- 82
- 66
Annual cashflow statement for Resonance Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.021 | 0.136 | 0.353 | 0.03 | 0.092 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.62 | 1.31 | 1.17 | -1.46 | -0.157 |
| Capital Expenditures | -0.348 | -0.251 | -0.396 | -0.704 | -0.468 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.348 | -0.251 | -0.396 | -0.704 | -0.468 |
| Financing Cash Flow Items | — | -0.015 | 0 | -0.037 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.25 | 2.82 | 1.19 | -0.107 | -0.082 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.53 | 3.89 | 1.88 | -2.07 | -0.422 |